Compare QMCO & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QMCO | ANIK |
|---|---|---|
| Founded | 1980 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.2M | 134.8M |
| IPO Year | N/A | 1993 |
| Metric | QMCO | ANIK |
|---|---|---|
| Price | $7.36 | $9.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $16.50 | $16.00 |
| AVG Volume (30 Days) | ★ 535.6K | 154.0K |
| Earning Date | 02-11-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $256,949,000.00 | $112,806,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.51 | $4.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 30.55 |
| 52 Week Low | $6.22 | $7.87 |
| 52 Week High | $41.00 | $18.37 |
| Indicator | QMCO | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 45.70 | 48.82 |
| Support Level | $7.35 | $9.31 |
| Resistance Level | $7.98 | $9.85 |
| Average True Range (ATR) | 0.49 | 0.20 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 55.85 | 39.45 |
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.